Read + Share
Shoemaker RH, Panettieri RA Jr, Libutti SK, Hochster HS, et al. Development of an aerosol intervention for COVID-19 disease: Tolerability of
soluble ACE2 (APN01) administered via nebulizer. PLoS One 2022;17:e0271066.
PMID: 35816490
|
 |
|
Shoemaker RH, Panettieri RA Jr, Libutti SK, Hochster HS, et al. Development of an aerosol intervention for COVID-19 disease: Tolerability of
soluble ACE2 (APN01) administered via nebulizer. PLoS One 2022;17:e0271066.
PMID: 35816490
|
|
|
|